Choline

Choline

SCHEMBL2222247

C[N+](C)(C)CCO.O=C([O-])[O-].[H+]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
MEN1 O00255 1/20 0.63
KMT2A Q03164 1/20 0.63
CYP3A4 P08684 1/20 0.63
SLC5A7 Q9GZV3 1/20 0.63
GALR3 O60755 2/20 0.41
ACHE P22303 1/20 0.39
CHRM5 P08912 3/20 0.37
CHRM1 P11229 3/20 0.37
CHRM3 P20309 3/20 0.37
CYP2C19 P33261 3/20 0.37
CHRM2 P08172 2/20 0.37
CHRM4 P08173 2/20 0.37
HTR1A P08908 2/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNA7 P36544 2/20 0.37
CHRNA4 P43681 2/20 0.37
ADRA2A P08913 1/20 0.37
ADRA1A P35348 1/20 0.37
PGR P06401 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Choline SCHEMBL119824 0.97 LMNA (0.67) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL8815341 0.94 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL1686210 0.94 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL1686208 0.94 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL30113090 0.92 LMNA (0.60) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL31575663 0.89 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL316506 0.89 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL119826 0.89 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL10630113 0.89 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7
Choline SCHEMBL1052170 0.89 LMNA (0.63) LMNAMEN1KMT2ACYP3A4SLC5A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1375545-B1 CATALYST AND PROCESS FOR THE TRIMERISATION OF ISOCYANATES VENCOREX FRANCE (FR) 2016-06-29 EP claimed
US-20040006139-A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof DEGUSSA AG (DE) 2004-01-08 US claimed
EP-1027380-B1 CATALYST AND METHOD FOR TRIMERIZATION OF ISOCYANATES RHODIA CHIMIE SA (FR) 2003-10-08 EP claimed
US-5693599-A Flux washing agent MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1997-12-02 US claimed
US-5538832-A Developing solution for producing printed circuit boards and a process for producing printed circuit boards wherein the developing solution comprises a quaternary ammonium hydroxide and a quaternary ammonium carbonate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1996-07-23 US claimed
CN-112204065-B Process for preparing polyisocyanate polymers and polyisocyanurate plastics 科思创知识产权两合公司 2023-03-28 CN disclosed
CN-114680199-A Method for improving frost resistance of flavor oil 丰益(上海)生物技术研发中心有限公司 2022-07-01 CN disclosed
CN-110062794-B Hard coating with high chemical and mechanical resistance 科思创德国股份有限公司 2022-05-13 CN disclosed
CN-110785449-B Coloured plastics based on crosslinked polyisocyanates 科思创德国股份有限公司 2022-04-05 CN disclosed
CN-110446737-B Formation of coatings by separate application of polyisocyanate composition and crosslinking catalyst 科思创德国股份有限公司 2022-04-01 CN disclosed
CN-109071762-B Polyisocyanurate plastic containing siloxane group and method for producing same 科思创德国股份有限公司 2022-03-11 CN disclosed
CN-113631545-A Polyisocyanurate materials as electrical potting compounds 科思创知识产权两合公司 2021-11-09 CN disclosed
US-20130165694-A1 PROCESS FOR THE SYNTHESIS OF CHOLINE SALTS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-06-27 US disclosed
EP-2516382-A2 PROCESS FOR THE SYNTHESIS OF CHOLINE SALTS E.I. Du Pont De Nemours And Company (US) 2012-10-31 EP disclosed
WO-2011084765-A2 PROCESS FOR THE SYNTHESIS OF CHOLINE SALTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-14 WO disclosed
US-20040006139-A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof DEGUSSA AG (DE) 2004-01-08 US disclosed
US-6166232-A Process for producing ester quats AKZO NOBEL NV (NL) 2000-12-26 US disclosed
US-5693599-A Flux washing agent MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1997-12-02 US disclosed
US-5538832-A Developing solution for producing printed circuit boards and a process for producing printed circuit boards wherein the developing solution comprises a quaternary ammonium hydroxide and a quaternary ammonium carbonate MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1996-07-23 US disclosed
US-5516928-A REACTION OF ISOPHORONE AND HYDROGEN CYANIDE USING QUATERNARY AMMONIUM CATALYST BASF AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006139-A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof PDK1, PC, PDK4 LMNA 1770/4885MEN1 1006/4885KMT2A 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.